In veterinary medicine, beta-lactam antibiotics are arguably
|
|
- Garry Simon
- 6 years ago
- Views:
Transcription
1 MICROBIAL DRUG RESISTANCE Volume 22, Number 4, 2016 ª Mary Ann Liebert, Inc. DOI: /mdr Emergence of Carbapenemase-Producing Escherichia coli Isolated from Companion Animals in Algeria Massilia Yousfi, 1 Abdelaziz Touati, 1 Assia Mairi, 1 Lucien Brasme, 2,3 Alima Gharout-Sait, 1 Thomas Guillard, 2,3 and Christophe De Champs 2,3 The emergence and worldwide spread of carbapenemase-producing Enterobacteriaceae is of great concern to public health. The aim of this study was to investigate the occurrence of carbapenemase-producing Escherichia coli in companion animals in Algeria. Two hundred fecal samples were obtained from healthy and diseased s and cats in one veterinary office and private owners in Bejaia city, Algeria, during November 2014 to March Isolates were screened by polymerase chain reaction for the presence of carbapenemase, acquired plasmidic AmpC (pampc) and extended-spectrum beta-lactamase genes. Five carbapenemase-producing E. coli isolates were detected including four OXA-48-producing isolates and one isolate producing NDM-5. Coexpression of ESBL and pampc genes was observed in these isolates. Phylogenetic grouping revealed that these isolates belonged to A and D phylogroups. The results of this study show that carbapenemase-producing E. coli spread to the companion animals in Algeria. Introduction In veterinary medicine, beta-lactam antibiotics are arguably the most important and widely used antimicrobial class for treating bacterial infections, including those caused by Enterobacteriaceae. 23 A large variety of beta-lactams is currently licensed for use in veterinary medicine and thus provides opportunity for selection pressure in the development of beta-lactam resistance. Indeed, beta-lactam resistance, including resistance to extended-spectrum beta-lactams, has now been increasingly observed in bacteria of animal origin and of human health concern. 16 During the last decade, the emergence of carbapenemaseproducing strains among Gram negative bacilli is remarkable. In Enterobacteriaceae, the carbapenemases belong to three types, the metallo-b-lactamases (MbLs), Klebsiella pneumoniae carbapenemases (KPC)-type, and the OXA-48 type enzymes. 27 The MBLs of Ambler class B are active against penicillins, older and newer cephalosporins, and carbapenems, but not aztreonam. 27 Recently, the emergence and dissemination of NDM-1 (New Delhi metallo b-lactamase) from India has garnered much attention. 23 The NDM-type b-lactamase was first isolated in 2009 from a Swedish patient returning from India. bla NDM has now spread to all inhabited continents and is carried by multiple Gram-negative species. 28 Although OXA-48 hydrolyses penicillins at a high level, it hydrolyses carbapenems only at a low level. In addition, it shows very weak activity against extended-spectrum cephalosporins. The OXA-48 type carbapenemases are found most commonly in Escherichia coli and K. pneumoniae, and are endemic in Turkey, northern Africa, and India. 21 The KPC exhibit activity against a wide spectrum of b-lactams, including penicillins, older and newer cephalosporins, aztreonam, and carbapenems. 27 Reports on carbapenemase-producing bacteria in animals are rare, but are increasing. Isolates of E. coli and Salmonella producing carbapenemase VIM-1 were recovered from pigs in Germany. 8,9 Poirel et al., reported one Acinetobacter baumannii isolate expressing carbapenemase OXA-23 recovered from cattle in France 20 and NDM-1-producing A. baumannii and Acinetobacter lwoffii isolates were reported from porcine and chicken sources in south China. 30 Concerning carbapenem resistance among Gram-negative bacteria isolated from companion animals, only two reports were published, including isolates of E. coli producing NDM- 1 reported from USA 25 and OXA-48 producing E. coli and K. pneumoniae identified in Germany. 26 These indicate that 1 Laboratoire d Ecologie Microbienne, FSNV, Université de Bejaia, Bejaia, Algérie. 2 Laboratoire de Bactériologie Virologie-Hygiène Hospitalière, CHU Reims, Hôpital Robert DEBRE, Reims, France. 3 EA4687 SFR CAP-Santé (FED 4231), Université de Reims-Champagne-Ardenne, Reims, France. 342
2 NDM-5 AND OXA-48 IN ESCHERICHIA COLI FROM PETS 343 carbapenemase-producing isolates are an emerging problem and can constitute a serious threat for public health. In Algeria, no studies have been published on antimicrobial resistance in companion animals and no data were available. This study aimed to determine the prevalence of colonization by carbapenemase-producing E. coli recovered from companion animals in Algeria. Materials and Methods Bacterial strains A total of 200 rectal swabs were obtained from healthy (i.e., pets admitted to veterinary office for vaccination) and diseased s and cats (for diagnostic investigation) in one veterinary office and private owners in Bejaia city, Algeria, during November 2014 to March Swabs were analyzed for the presence of carbapenemase-producing E. coli within 4 hr of collection. Swabs were enriched in 10 ml nutrient broth (Fluka, St Louis, MO) containing ½ disc of 10 mg ertapenem (BioRad, Marnes La Coquette, France). After incubation at 37 C/ 24 hr, 100 ml of the culture were streaked on MacConkey agar (Fluka) plates containing imipenem (0.5 mg/l) and vancomycin (16 mg/l) to inhibit Gram-positive bacteria and incubated under aerobic conditions during 24 hr at 37 C. E. coli isolates were identified using Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (IVD MALDI Biotyper; Bruker Biospin SAS, Wissembourg, France). Antimicrobial susceptibility testing Antibiotic susceptibility was determined on Mueller Hinton agar using the standard disc diffusion procedure as described by the European Committee on Antimicrobial Susceptibility Testing. 7 The following antibiotics were tested: ticarcillin, ticarcillin clavulanic acid, piperacillin, piperacillin tazobactam, amoxicillin clavulanic acid, ceftazidime, cefotaxime, cefepime, cefoxitin, imipenem, ertapenem, meropenem, aztreonam, temocillin, amikacin, tobramycin, ciprofloxacin, chloramphenicol, tigecycline, and cotrimoxazole (BioRad). Determination of minimum inhibitory concentrations Isolates classified as resistant or intermediate to ertapenem by disk diffusion were further analyzed by determining the minimum inhibitory concentrations ( MICs) of imipenem, ertapenem, meropenem, doripenem, ceftazidime, cefotaxime, aztreonam, and piperacillin tazobactam by Etest (AB biomérieux, Marcy l Etoile, France). MICs were interpreted according to the breakpoints recommended by EUCAST. 7 Phenotypic carbapenemase detection The Modified Hodge Test (MHT) was performed on a Mueller Hinton agar (biomérieux, Marcy l Etoile, France) plate with both imipenem and meropenem (BioRad) with and without EDTA 0.5M (5 ml on the ertapenem disc) and E. coli ATCC as the indicator organism for detection of carbapenemases as described previously. 6,7 In addition, a double-disc synergy test was designed for detecting MbLs as described previously. 29 K. pneumoniae ATCC BAA-1705 was used as a positive control and K. pneumoniae ATCC 8291T was used as a negative control. Detection of antibiotic resistance genes Carbapenemase encoding genes, bla KPC, bla VIM, bla IMP, bla NDM-1, bla OXA-23-like, bla OXA-58-like, and bla OXA-48-like, were screened as previously described. 10 Polymerase chain reaction (PCR) assays for the presence of genes encoding for b-lactamases (bla TEM, bla SHV, and bla CTX-M ) and for plasmid-mediated AmpC-type genes (bla ACC, bla FOX, bla MOX, bla DHA, bla CMY, and bla MIR ) were performed as described previously. 15 A multiplex real-time PCR assay was used to screen the presence of qnra, qnrb, qnrs, qnrc, qnrd, oqxab, and qepa genes as described previously. 11,13 Pyrosequencing method was used for the rapid detection of aac(6 )-Ib-cr determinant. 12 PCR products were sequenced and the sequencing results were compared to reported sequences available in GenBank. Phylogenetic groups and virulence genotyping of E. coli PCRs were performed to determine the phylogenetic groups (A, B1, B2, C, D, E, F, and clade I) of the E. coli isolates, using the newly revised Clermont method. 5 The presence of 11 virulence factors was investigated by PCR. These factors included sfa/foc (S and F1C fimbriae), papg alleles (G adhesin classes of P fimbriae), papc (C adhesin classes of P fimbriae), hlya (alpha-hemolysin A), cnf (cytotoxic necrotizing factor 1), fyua (genes of yersiniabactin), iuta (aerobactin receptor), ibea (invasion protein IbeA), stx1, 22 stx2 4, and eae. 19 Results During a 5-month period, we collected 200 sample swabs taken from 200 pets from a veterinary practice (93 s and 81 cats) and private owners (23 s and 3 cats). A total of 173 of companion animals were healthy and 27 were diseased. We isolated five E. coli isolate-producing carbapenemase from five animals. The overall prevalence of carbapenemase isolates in the 200 animals was 2.5%. The prevalence of E. coli-producing carbapenemase in s was 2.58% and in cats was 2.83%. Four isolates were from healthy pets (prevalence of 2.3%; n = 173) and one isolate was obtained from a diseased cat admitted to a veterinary office for a respiratory infection (prevalence of 3.7%; n = 27). All isolates were recovered from the veterinary office. These E. coli isolates were suspected to produce carbapenemases by Hodge test, which are not inhibited by EDTA, except for one isolate (S174). The antibiotic susceptibility profiles of the carbapenemaseproducing E. coli strains isolated in this study are shown in Table 1. E. coli S174 isolate showed a synergy between aztreonam and co-amoxiclav when tested by DD-test (Fig. 1). Concerning nonbeta-lactam antibiotics, isolates showed different susceptibility pattern (Table 1), but all isolates were susceptible to colistin, tigecycline, and amikacin. The antibiotics MICs are shown in Table 1. Except E. coli S174 isolate, which showed high carbapenem MICs (24 mg/ L for doripenem and >32 mg/l for ertapenem, meropenem,
3 344 YOUSFI ET AL. Table 1. Characteristics of Escherichia coli Strains Producing Carbapenemase Isolated from Pets MIC (mg/l) ETP MEM DOR IMP ATM CAZ CTX TZP b-lactamases and PMQR identified Resistance phenotype Virulence genes Phylogenetic group Isolate Origin OXA-48, TEM D fyua ERT, TIC, TCC, AMC, PIP, TZP, TEM, TOB, GEN, SXT S100 Healthy OXA-48, TEM-1, CMY-2 ERT, TIC, TCC, AMC, PIP, TZP, TEM, CAZ, FOX, CIP, NAL, SXT U fyua, iuta S132 Diseased cat >32 >32 24 >32 >256 >256 >32 >256 NDM-5, CTX-M-15, CMY-42, AAC-(6 )- Ib-cr ERT, TIC, TCC, AMC, PIP, TZP, FEP, FOX, CTX, CAZ, ATM, IPM, TEM, TOB, CIP, NAL A fyua, iuta S174 Healthy OXA A fyua ERT, TIC, TCC, AMC, PIP, TZP, TEM, CIP, NAL, SXT S192 Healthy OXA-48, TEM D fyua ERT, TIC, TCC, AMC, PIP, TZP, TEM, TOB, GEN, SXT S99 Healthy cat AMC, amoxicillin clavulanate; ATM, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; CTX, cefotaxime; DOR, doripenem; ERT, ertapenem; FOX, cefoxitin; GEN, gentamicin; IPM, imipenem; MIC, minimum inhibitory concentration; NAL, nalidixic acid; PIP, piperacillin; PMQR, plasmid-mediated quinolone resistance; SXT, co-trimoxazole; TCC, ticarcillin clavulanate; TEM, temocillin; TIC, ticarcillin; TOB, tobramycin; TZP, piperacillin tazobactam; U, unknown. FIG. 1. Result of susceptibility testing of the Escherichia coli isolate S174. From the top and from left to right: TIC, ticarcillin; PIP, piperacillin; CTX, cefotaxime clavulanate; CCAZ, ceftazidime clavulanate; AMC, amoxicillin clavulanate; TCC, ticarcillin clavulanate; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; CPO, cefpirome; ATM, aztreonam; IPM, imipenem; TZP, piperacillin tazobactam; FOX, cefoxitin; CFEP, cefepime clavulanate; ERT, ertapenem. and imipenem), the other isolates showed very low MICs to carbapenems ranging from 0.19 mg/l to doripenem to 2 mg/l to ertapenem. Genotypic analysis of antibiotic resistance genes The presence of the bla OXA-48 gene in four isolates and bla NDM-5 in one isolate (S174) were confirmed with PCR amplification and sequencing. In addition to carbapenemase determinants, four isolates produced other beta-lactamases (Table 1). The unique detected plasmid-mediated quinolone resistance (PMQR) gene was aac(6 )-Ibcr identified in E. coli S174 producing NDM-5, CMY-42, and CTX-M-15. No isolates were found to carry qnr, qepa,oroqxab determinants. E. coli phylogenetic groups and virulence factors Analysis of E. coli phylogroups showed that these isolates belong to phylogroup A (S174 and S192), phylogroup D (S99 and S100), and unknown phylogroup (S132) (Table 1). All isolates carried fyua gene encoding yersiniabactin. Two isolates, S174 and S132, were also found to carry iuta encoding aerobactin receptor. Discussion Although carbapenems are not registered for use in animals in any major jurisdiction, a case of use of these molecules has been reported in s for the treatment of urinary tract infection and postoperative infection caused by multidrugresistant E. coli. 1 Indeed, the emergence of carbapenemaseproducing bacteria is a major public health problem, mainly in
4 NDM-5 AND OXA-48 IN ESCHERICHIA COLI FROM PETS 345 the community setting. In our study, we report for the first time the emergence of carbapenemase-producing E. coli in companion animals in Algeria and in Africa. Until now, only two reports on carbapenemase-producing Gram-negative bacteria were reported from companion animals, NDM-1-producing E. coli isolates reported in the USA 25 and OXA-48 in E. coli and K. pneumoniae isolates in Germany. 26 In the Shaheen study, 944 canine and feline clinical E. coli isolates from different veterinary laboratories recovered between May 2008 and 2009 were analyzed. Of these, six different isolates were found to produce bla NDM-1 genes. 25 Reports on NDM-producing isolates in Algeria are limited and concern essentially isolates of A. baumannii recovered from clinical specimens. 3,17 NDM-5 was first reported by Hornsey et al. 14 NDM-5 differed from existing enzymes due to substitutions at positions 88 (Val3Leu) and 154 (Met3Leu). 14. Sassi et al. reported NDM-5-producing E. coli recovered from urine and blood specimens of three patients admitted to the University Hospital of Annaba, Algeria. These isolates coexpressed bla CTX-M-15 and bla TEM In our study, besides NDM-5, the E. coli S174 isolate coexpressed CTX-M-15 and CMY-42 allowing the isolate to resist all beta-lactams available. Zhang et al. reported two clinical isolates of E. coli harboring either bla NDM-1, bla CTX-M-14, and bla CMY-42 or bla NDM-1, bla SHV-12, bla CTX-M-14,andbla CMY Detection of plasmidic AmpC (pampc) in these types of isolates is only possible with molecular screening by PCR, because isolates harboring MbL are resistant to all betalactams, except aztreonam. So the production of pampc is masked by MbL. Thus, we recommend using PCR multiplex to detect the coproduction of pampc in isolates producing MbL. In addition a DD-test with aztreonam and co-amoxiclav should be used to screen the coexpression of ESBL. OXA-48 was first described in 2001 in a K. pneumoniae isolate from a patient in Istanbul, Turkey. It is suggested that the main reservoirs of OXA-48-harbouring K. pneumoniae and E. coli are in North African countries and Turkey. 18 OXA-48 E. coli and K. pneumoniae producers were isolated from s for the first time in 2012 in Germany. 26 In this study, the authors reported eight carbapenem-resistant K. pneumoniae (n = 5) and E. coli (n = 3) isolated from six s admitted to a veterinary clinic producing the bla OXA-48 gene. These E. coli isolates also coproduced bla CMY-2, bla SHV-12,andbla CTX-M In Algeria, there is only one report on Enterobacteriaceae isolates producing OXA-48 in a military hospital. 2 In this study, the authors reported one isolate of E. coli belonging to phylogroup B1 producing OXA In our study, in three of the four isolates producing OXA-48, coproduction of additional beta-lactamases conferred resistance to extendedspectrum beta-lactams, cephamycins, and aztreonam. We used two steps for the isolation of E. coli-producing carbapenemases. These methods allowed obtaining both types of carbapenemase NDM and OXA-48. When we analyze the carbapenem MICs obtained, we note that isolates harboring only bla OXA-48 showed very low carbapenem MICs ranging from 1.5 to 2 mg/l for ertapenem and from 0.38 to 0.75 mg/l for imipenem. Thus, to select Enterobacteriaceae-producing OXA-48, we recommend using, in enrichment and isolation steps, ertapenem at a final concentration of 0.5 mg/l. In terms of international spread, there are three major routes of NDM acquisition, nosocomial, personal travel, and community acquisition. 28 Unfortunately, information regarding the foreign travel history of the owners were not collected by the veterinary office at the time of the medical visit. Thus, the origin of these carbapenemase-producing isolates was uncertain. Phylogenetic analyses have shown that E. coli strains fall into four main phylogroups (A, B1, B2, and D), in which groups A and B1 typically contain commensal isolates and isolates of groups B2 and D are considered to be more likely carrying pathogenicity-associated genes. 5 In our study, isolates were assigned to phylogroup A and D. One limitation of our study is the small size of our samples. Therefore, we agree that a potential caveat of our study could be the extrapolation of our results to the general cat and population at the national level. We should be cautious. Nonetheless, only one veterinary practice was involved because there is only veterinary practice for companion animals in Bejaia city. It should be pointed out that the adoption of companion animals by private owners in Algeria is a phenomenon that has appeared in recent years. In general, these owners belong to a high socioeconomic class. Even though our study was conducted in one veterinary practice in Bejaia city, a surveillance program for screening of carbapenemase-producing isolates among healthy companion animals should be established. In conclusion, our study demonstrates that the prevalence of carbapenemase-producing E. coli in companion animals in Algeria is 2.5%. Our findings strongly suggest that isolates producing carbapenemase are currently circulating among companion animals and can act as a reservoir of gene transmission between humans and animals. Further studies are needed to survey the dissemination of carbapenemaseproducing strains in the population. Acknowledgment The authors are grateful to J. Madoux for her contribution to this work. Disclosure Statement No competing financial interests exist. References 1. Abraham, S., H.S. Wong, J. Turnidge, J.R. Johnson, and D.J. Trott Carbapenemase-producing bacteria in companion animals: a public health concern on the horizon. J. Antimicrob. Chemother. 69: Agabou, A., A. Pantel, Z. Ouchenane, N. Lezzar, S. Khemissi, D. Satta, A. Sotto, and J.P. Lavigne First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalized at a military hospital in Algeria. Eur. J. Clin. Microbiol. Infect. Dis. 33: Bakour, S., A. Touati, T. Bachiri, F. Sahli, D. Tiouit, M. Naim, M. Azouaou, and J.M. Rolain First report of 16S rrna methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-b-lactamase NDM- 1 in Algerian hospitals. J. Infect. Chemother. 20: Cebula, T.A, W.L. Payne, and P. Feng Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J. Clin. Microbiol. 33:
5 346 YOUSFI ET AL. 5. Clermont, O., J.K. Christenson, E. Denamur, and D.M. Gordon The Clermont Escherichia coli phylotyping method revisited: improvement of specificity and detection of new phylo-groups. Environ. Microbiol. Rep. 5: Clinical and Laboratory Standards Institute [CLSI] Performance Standards for Antimicrobial Susceptibility Testing; 24th Informational Supplemet, M100-S24, CLSI document. Wayne, PA:CLSI. 7. EUCAST EUCAST Clinical Breakpoint Table v. 4.0 Enterobacteriaceae. Available at clinical_breakpoints (Online, accessed April 17, 2015.) 8. Fischer, J., I. Rodriguez, S. Schmoger, A. Friese, U. Roesler, R. Helmuth, and B. Guerra Escherichia coli producing VIM-1 carbapenemase isolated on a pig farm. J. Antimicrob. Chemother. 67: Fischer, J., I. Rodriguez, S. Schmoger, A. Friese, U. Roesler, R. Helmuth, and B. Guerra Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. J. Antimicrob. Chemother. 68: Gharout-Sait, A., S.A. Alsharapy, L. Brasme, A. Touati, R. Kermas, S. Bakour, T. Guillard, and C. de Champs Enterobacteriaceae isolates carrying the New Delhi metallo-b-lactamase gene in Yemen. J. Med. Microbiol. 63: Guillard, T., C. de Champs, H. Moret, X. Bertrand, J.M. Scheftel, and E. Cambau High-resolution melting analysis for rapid characterization of qnr alleles in clinical isolates and detection of two novel alleles, qnrb25 and qnrb42. J. Antimicrob. Chemother. 67: Guillard, T., V. Duval, H. Moret, L. Brasme, V. Vernet- Garnier, and C. de Champs Rapid detection of aac(6 )-Ib-cr quinolone resistance gene by pyrosequencing. J. Clin. Microbiol. 48: Guillard, T., H. Moret, L. Brasme, A. Carlier, V. Vernet-Garnier, E. Cambau, and C. de Champs Rapid detection of qnr and qepa plasmid-mediated quinolone resistance genes using real-time PCR. Diagn. Microbiol. Infect. Dis. 70: Hornsey, M., L. Phee, and D.W. Wareham A novel variant, NDM-5, of the New Delhi metallo-blactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 55: Kermas, R., A. Touati, L. Brasme, E. Le Magrex-Debar, S. Mehrane, F.X. Weill, and C. De Champs Characterization of extended-spectrum beta-lactamase producing Salmonella enterica Serotype Brunei and Heidelberg at the Hussein Dey Hospital in Algiers (Algeria). Food Borne Pathog. Dis. 9: Li, X.Z., M. Mehrotra, S. Ghimire, and L. Adewoye Beta-Lactam resistance and beta-lactamases in bacteria of animal origin. Vet. Microbiol. 121: Mesli, E., M. Berrazeg, M. Drissi, S.N. Bekkhoucha, and J.M. Rolain Prevalence of carbapenemase-encoding genes including New Delhi metallo-b-lactamase in Acinetobacter species, Algeria. Int. J. Infect. Dis. 17:e739 e Nordmann, P., and L. Poirel The difficult-tocontrol spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin. Microbiol. Infect. 20: Paton, A.W., and J.C. Paton Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaea, enterohemorrhagic E. coli hlya, rfbo111, and rfbo157. J. Clin. Microbiol. 36: Poirel, L., B. Bercot, Y. Millemann, R.A. Bonnin, G. Pannaux, and P. Nordmann Carbapenemaseproducing Acinetobacter spp. in cattle, France. Emerg. Infect. Dis. 18: Poirel, L., A. Potron, and P. Nordmann OXA-48- like carbapenemases: the phantom menace. J. Antimicrob. Chemother. 67: Pollard, D.R., W.M. Johnson, H. Lior, S.D. Tyler, and K.R. Rozee Differentiation of Shiga toxin and Vero cytotoxin type 1 genes by polymerase chain reaction. J. Infect. Dis. 162: Rubin, J.E., and J.D. Pitout Extended-spectrum b-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals. Vet. Microbiol. 170: Sassi, A., L. Loucif, S.K. Gupta, M. Dekhil, H. Chettibi, and J.M. Rolain NDM-5 carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob. Agents Chemother. 58: Shaheen, B.W., R. Nayak, and D.M. Boothe Emergence of a New Delhi metallo-b-lactamase (NDM-1)- encoding gene in clinical Escherichia coli isolates recovered from companion animals in the United States. Antimicrob. Agents Chemother. 57: Stolle, I., E. Prenger-Berninghoff, I. Stamm, S. Scheufen, E. Hassdenteufel, S. Guenther, A. Bethe, Y. Pfeifer, and C. Ewers Emergence of OXA-48 carbapenemaseproducing and Escherichia coli Klebsiella pneumoniae in s. J. Antimicrob. Chemother. 68: Tzouvelekis, L.S., A. Markogiannakis, M. Psichogiou, P.T. Tassios, and G.L. Daikos Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25: Wailan, A.M., and D.L. Paterson The spread and acquisition of NDM-1: a multifactorial problem. Expert Rev. Anti Infect. Ther. 12: Yong, D., K. Lee, J.H. Yum, H.B. Shin, G.M. Rossolini, and Y. Chong Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40: Zhang, W.J., Z. Lu, S. Schwarz, R.M. Zhang, X.M. Wang, W. Si, S. Yu, L. Chen, and S. Liu Complete sequence of the bla NDM-1 -carrying plasmid pndm-ab from Acinetobacter baumannii of food animal origin. J. Antimicrob. Chemother. 68: Zhang, X., D. Lou, Y. Xu, Y. Shang, D. Li, X. Huang, Y. Li, L. Hu, L. Wang, and F. Yu First identification of coexistence of bla NDM-1 and bla CMY-42 among Escherichia coli ST167 clinical isolates. BMC Microbiol. 13:282. Address correspondence to: Abdelaziz Touati, PhD Laboratoire d Ecologie Microbienne FSNV Université de Bejaia Bejaia Algérie ziz1999@yahoo.fr
ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More information1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS
PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationβ-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018
β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa 12-14 March 2018 Antibiotic resistance center Institut Pasteur du Maroc Enterobacteriaceae (E. coli, Salmonella, ) S. aureus
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationPresenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update
Emergence of invasive Carbapenem Resistant Enterobacteriaceae CRE infection at RCWMCH Ombeva Oliver Malande, Annerie du Plessis, Colleen Bamford, Brian Eley Presenter: Ombeva Malande Red Cross Children's
More informationOvernight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients
TABLE 1. Origin and carbapenem resistance characteristics of the 64 Acinetobacter baumannii stock D-750 Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationWitchcraft for Gram negatives
Witchcraft for Gram negatives Dr Subramanian S MD DNB MNAMS AB (Medicine, Infect Dis) Infectious Diseases Consultant Global Health City, Chennai www.asksubra.com Drug resistance follows the drug like a
More informationThe impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker
The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker sbaker@oucru.org Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam Outline The impact of antimicrobial
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationPrevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia
Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia Ruta Paberza 1, Solvita Selderiņa 1, Sandra Leja 1, Jelena Storoženko 1, Lilija Lužbinska 1, Aija Žileviča 2*
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More informationAPPENDIX III - DOUBLE DISK TEST FOR ESBL
Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January
More informationETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens
ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens Ruben Tommasi, PhD Chief Scientific Officer ECCMID 2017 April 24, 2017 Vienna, Austria
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationMicrobiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:
Microbiology Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention June 2017 MeshHp (VS) Medical Care Center Dr. Eberhard & Partner Dortmund (ÜBAG) www.labmed.de MVZ Dr. Eberhard &
More informationPROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains
PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationOther β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL
Other β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL David P. Nicolau, PharmD, FCCP, FIDSA Director, Center for Anti-Infective Research and Development Hartford Hospital
More informationAddressing the evolving challenge of β-lactamase mediated antimicrobial resistance: ETX2514, a next-generation BLI with potent broadspectrum
Addressing the evolving challenge of β-lactamase mediated antimicrobial resistance: ETX2514, a next-generation BLI with potent broadspectrum activity against Class A, C and D enzymes Alita Miller, PhD
More informationA SURVEY OF CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE IN COMPANION
AAC Accepted Manuscript Posted Online 11 January 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.02383-15 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 A
More informationAnaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark
Anaerobe bakterier og resistens Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark Programme anaerobic bacteria Carbapenem and metronidazole resistance New
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationAntibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae isolates in a Tertiary Care Center
JMID/ 2018; 8 (4):153-157 Journal of Microbiology and Infectious Diseases doi: 10.5799/jmid.493854 RESEARCH ARTICLE Antibiotic Therapy for ESBL and NDM producing Escherichia coli and Klebsiella pneumoniae
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationInternational Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI * PRABHAKAR C MAILAPUR, DEEPA
More informationFighting MDR Pathogens in the ICU
Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial
More informationAntimicrobial Resistance Strains
Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant
More informationEUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)
EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationTaiwan Surveillance of Antimicrobial Resistance (TSAR)
Taiwan Surveillance of Antimicrobial Resistance (TSAR) 2009 MIRL Symposium July 17, 2009 Tsai-Ling Yang Lauderdale ( ) Microbial Infections Reference Laboratory (MIRL) Division of Infectious Diseases,
More informationComparison of in vitro efficacy of ertapenem, imipenem and meropenem by the Enterobacteriaceae strains family
ORIGINAL AND CLINICAL ARTICLES Anaesthesiology Intensive Therapy 2013, vol. 45, no 2, 67 72 ISSN 1642 5758 DOI: 10.5603/AIT.2013.0015 www.ait.viamedica.pl Comparison of in vitro efficacy of ertapenem,
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationBreaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester
Breaking the Ring β-lactamases and the Great Arms Race Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester 2015 MFMER slide-1 Disclosures I have no relevant financial relationships
More informationInternational Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents 35 (2010) 227 234 Contents lists available at ScienceDirect International Journal of Antimicrobial Agents journal homepage: http://www.elsevier.com/locate/ijantimicag
More informationNew Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs
New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks
More informationAcinetobacter baumannii: from S to PDR
Acinetobacter baumannii: from S to PDR P. Plésiat French National Reference Center for Antibiotic Resistance University Hospital Jean Minjoz 25030 Besançon, France No conflict of interest! IDSA CID 2009,
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationBeta-lactamase Inhibitors May Induce Resistance to Beta-lactam Antibiotics in Bacteria Associated with Clinical Infections Bhoj Singh
Noto-are 14947537: Medicine. 2018-06-03. Beta-lactamase Inhibitors May Induce Resistance to Beta-lactam Antibiotics in Bacteria Associated with Clinical Infections Bhoj Singh Indian Veterinary Research
More informationDetection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary Care Hospital in North India
Original Article Vol. 25 No. 3 Ampc β-lactamase Production in Gram-Negative Bacilli:-Chaudhary U, et al. 129 Detection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationPresence of extended spectrum β-lactamase producing Escherichia coli in
1 2 Presence of extended spectrum β-lactamase producing Escherichia coli in wild geese 3 4 5 A. Garmyn* 1, F. Haesebrouck 1, T. Hellebuyck 1, A. Smet 1, F. Pasmans 1, P. Butaye 2, A. Martel 1 6 7 8 9 10
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationG. Valenza, S. Müller, C. Schmitt, D. Turnwald, T-T. Lam, M. Frosch, M. Abele-Horn, Y. Pfeifer
Evaluation of the VITEK AST-N1 card for detection of extended-spectrum beta-lactamases (ESBLs) in and compared to ESBL Etests and combination disk methods G. Valenza, S. Müller, C. Schmitt, D. Turnwald,
More informationAcinetobacter Resistance in Turkish Tertiary Care Hospitals. Zeliha KOCAK TUFAN, MD, Assoc. Prof.
Acinetobacter Resistance in Turkish Tertiary Care Hospitals Zeliha KOCAK TUFAN, MD, Assoc. Prof. Acinetobacter Problem Countries that have reported hospital outbreaks of carbapenem-resistant Acinetobacter
More informationETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae
ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;
More informationResearch & Reviews: Journal of Veterinary Sciences
Research & Reviews: Journal of Veterinary Sciences Antimicrobial Susceptibility Pattern of Gram Negative Bacteria Isolated from Feline Urinary Tract Infections (UTIs): A Retrospective Study from 2011 to
More informationWhat do we know about multidrug resistant bacteria in New Zealand s pet animals?
What do we know about multidrug resistant bacteria in New Zealand s pet animals? Eve Pleydell Animal and Marine Biosecurity Response Team, Ministry for Primary Industries Formerly: Institute of Veterinary,
More informationNon-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,
Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland, 2008-2016 Alicia Russell Federation of Infection Societies conference 14 th November 2018 alisia_russell BSAC
More informationCo-transfer of bla NDM-5 and mcr-1 by an IncX3 X4 hybrid plasmid in Escherichia coli 4
SUPPLEMENTARY INFORMATION ARTICLE NUMBER: 16176 DOI: 10.1038/NMICROBIOL.2016.176 Co-transfer of bla NDM-5 and mcr-1 by an IncX3 X4 hybrid plasmid in Escherichia coli 4 5 6 7 8 9 10 11 12 13 14 15 16 17
More informationActivity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
Journal of Antimicrobial Chemotherapy Advance Access published July 31, 2010 J Antimicrob Chemother doi:10.1093/jac/dkq278 Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia
More informationOriginal Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**
Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,
More informationGeorgios Meletis, Efstathios Oustas, Christina Botziori, Eleni Kakasi, Asimoula Koteli
New Microbiologica, 38, 417-421, 2015 Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin
More informationWhat does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh
What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh Disclosures Merck Research grant Clinical context of multiresistance Resistance to more classes of agents Less options
More informationStudy of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India
Research article Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India Mitali Chatterjee, 1 M. Banerjee, 1 S. Guha, 2 A.Lahiri, 3 K.Karak
More informationPrevention, Management, and Reporting of Carbapenem-Resistant Enterobacteriaceae
Prevention, Management, and Reporting of Carbapenem-Resistant Enterobacteriaceae Dawn Terashita MD, MPH Acute Communicable Disease Control Los Angeles County Department of Public Health September 28, 2017
More informationAvailable online at
Available online at www.annclinlabsci.org Time-Kill Synergy Tests of Tigecycline Combined with Imipenem, Amikacin, and Ciprofloxacin against Clinical Isolates of Multidrug-Resistant Klebsiella pneumoniae
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationDr Kamini Walia Indian Council of Medical Research
Dr Kamini Walia Indian Council of Medical Research The apex body in India for the formulation, coordination and promotion of biomedical research under Department of Health Research, Ministry of Health
More informationOutline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010
Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Antibiotic Susceptibility Pattern of Pseudomonas Aeruginosa Isolated From Various Clinical
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More informationResearch, National Health Research Institute, Zhunan, Taiwan. Received: May 1, 2008 Revised: June 4, 2008 Accepted: July 4, 2008
J Microbiol Immunol Infect. 2009;42:310-316 Prevalence of extended-spectrum β-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum
More information5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)
Multidrug Resistant Organisms (MDROs) Kasturi Shrestha, M.D. 05/11/2018 Objectives Define a multi-drug resistant organism (MDRO) Identify most challenging MDROs in healthcare Identify reasons for health
More informationComparison of Antibiotic Resistance and Sensitivity with Reference to Ages of Elders
Daffodil International University Institutional Repository DIU Journal of Science and Technology Volume 10, Issue 1-2, July 2015 2016-06-16 Comparison of Antibiotic Resistance and Sensitivity with Reference
More informationJOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH How to cite this article: SHOBHA K L, RAMACHANDRA L, RAO G, MAJUMDER S, RAO S P. EXTENDED SPECTRUM BETA-LACTAMASES (ESBL) IN GRAM NEGATIVE BACILLI AT A TERTIARY
More informationOriginal Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc.
Original Article Vol. 21 No.1 The optimum agent for ESBL screening and confirmatory tests:- Srisangkaew S & Vorachit M. 1 The Optimum Agent for Screening and Confirmatory Tests for Extended-Spectrum Beta-Lactamases
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationDetection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 12 (2015) pp. 578-583 http://www.ijcmas.com Original Research Article Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationEDUCATIONAL COMMENTARY THE RISE OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAE
ENTEROBACTERIACEAE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn CE Credits under Continuing
More informationVersion 1.01 (01/10/2016)
CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be
More informationDrug resistance analysis of bacterial strains isolated from burn patients
Drug resistance analysis of bacterial strains isolated from burn patients L.F. Wang, J.L. Li, W.H. Ma and J.Y. Li Inner Mongolia Institute of Burn Research, The Third Affiliated Hospital of Inner Mongolia
More informationMichael Hombach*, Guido V. Bloemberg and Erik C. Böttger
J Antimicrob Chemother 2012; 67: 622 632 doi:10.1093/jac/dkr524 Advance Access publication 13 December 2011 Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationGlobal Alliance for Infections in Surgery. Better understanding of the mechanisms of antibiotic resistance
Better understanding of the mechanisms of antibiotic resistance Antibiotic prescribing practices in surgery Contents Mechanisms of antibiotic resistance 4 Antibiotic resistance in Enterobacteriaceae 9
More informationJournal of Antimicrobial Chemotherapy Advance Access published October 3, 2011
Journal of Antimicrobial Chemotherapy Advance Access published October 3, 2011 J Antimicrob Chemother doi:10.1093/jac/dkr400 Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST)
More informationINCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS
INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS 1 Research Associate, Drug Utilisation Research Unit, Nelson Mandela University 2 Human Sciences Research Council,
More informationMultidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC)
Multidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC) Octavie Lunguya 1, Veerle Lejon 2, Sophie Bertrand 3, Raymond Vanhoof 3, Jan Verhaegen 4, Anthony M. Smith 5, Benedikt
More informationCharacterization of isolates from a multi-drug resistant outbreak of Shiga toxin-producing Escherichia. coli O145 infections in the United States
AAC Accepts, published online ahead of print on 19 September 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.05545-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More information